Effectiveness and safety of secukinumab in 608 patients with psoriatic arthritis in real life: a 24-month prospective, multicentre study

Objectives To evaluate in a multicentric Italian cohort of patients with psoriatic arthritis (PsA) on secukinumab followed for 24 months: (1) the long-term effectiveness and safety of secukinumab, (2) the drug retention rate and minimal disease activity (MDA), (3) differences in the outcomes accordin...

Cijeli opis

Bibliografski detalji

Glavni autori:	Andrea Doria, Alberto Cauli, Roberta Ramonda, Ennio Lubrano, Maria Sole Chimenti, Carlo Salvarani, Rosario Foti, Elisa Visalli, Giorgio Amato, Luisa Costa, Raffaele Scarpa, Fabio Massimo Perrotta, Nicolò Girolimetto, Antonio Carriero, Mariagrazia Lorenzin, Antonio Marchesoni, Angelo Semeraro, Leonardo Santo, Augusta Ortolan, Elena Fracassi, Giulia Virelli, Marco Masia, Rosalinda Fanizzi, Antonio Carletto, Salvatore d’Angelo, Desiati Francesca, Giulia Lavinia Fonti, Emanuela Praino
Format:	Artigo
Jezik:	Inglês
Izdano:	BMJ Publishing Group 2021-02-01
Serija:	RMD Open
Online pristup:	https://rmdopen.bmj.com/content/7/1/e001519.full
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!